Two Investigational Treatments for ALS Show Glimmer of Hope

TribeNews
By TribeNews 11 Views Add a Comment
0 Min Read

MedPage Today) — The first four treatments in a platform trial for amyotrophic lateral sclerosis (ALS) failed to reach key endpoints in phase II studies, but two treatments — pridopidine and CNM-Au8 — showed glimmers of hope.
All treatments…

Leave a Comment
Ads Blocker Image Powered by Code Help Pro

Ads Blocker Detected & This Is Prohibited!!!

We have detected that you are using extensions to block ads and you are also not using our official app. Your Account Have been Flagged and reported, pending de-activation & All your earning will be wiped out. Please turn off the software to continue

You cannot copy content of this app